NeuroSense Therapeutics Ltd. Diluted Earnings Loss Per Share
NeuroSense Therapeutics Ltd. (NRSN) reported Diluted Earnings Loss Per Share of -$0.83 per share for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2024-04-04
| Period end | Diluted Earnings Loss Per Share 6 month | Diluted Earnings Loss Per Share 12 month |
|---|---|---|
| 2023-12-31 | -$0.83 20-F · filed 2024-04-04 | |
| 2023-06-30 | -$0.77 6-K · filed 2023-08-16 | |
| 2022-12-31 | -$1.07 20-F · filed 2024-04-04 | |
| 2022-06-30 | -$0.55 6-K · filed 2023-08-16 | |
| 2021-12-31 | -$0.65 20-F · filed 2024-04-04 | |
| 2021-06-30 | -$1.62 6-K/A · filed 2023-01-19 | |
| 2020-12-31 | -$0.51 20-F · filed 2023-03-22 |